CanniMed Therapeutics CEO Brent Zettl has resigned, effective immediately, as Aurora Cannabis nears completion of its acquisition of the medical marijuana company.
Zettl, who helped co-found the Saskatoon-based licensed producer in 1988, is pursuing other opportunities, the companies said in a statement.
He has agreed to remain available to CanniMed and Aurora as they integrate the two companies.
Financial news and insights
delivered to your email every Saturday.
Get weekly money news
Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
Aurora’s senior vice president of business integration Andre Jerome has been appointed as interim chief executive.
In January, Aurora struck a stock-and-cash deal valued at $1.1 billion to buy CanniMed.
The agreement ended a sometimes-terse takeover battle between the two marijuana companies.